FDA Inspection
BioLife Plasma Services L.P.BioLife Plasma Services L.P. – FDA Inspection, Feb 20, 2026
Record Details
This FDA Inspection record concerns BioLife Plasma Services L.P., with an inspection on February 20, 2026, issued by the Detroit District Office, covering biologics.
View Company Profile
ID · c4740dc6-e509-44bc-9e6d-b95e0bd3d094
Inspection Facts
- Inspection number
- 1286084
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 601.12(c)Moderate changes to an approved application
- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.160(a)(1)Concurrent documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BioLife Plasma Services L.P.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 25, 2023 | Not classified | Detroit District Office | |
| August 11, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 24, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 16, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for BioLife Plasma Services L.P.
- FDA Inspection 1204022 - 2023-04-25
- FDA Inspection 1028668 - 2017-08-11
- FDA Inspection 788290 - 2012-05-24
- FDA Inspection 682760 - 2010-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.